Powered by Madgex Job Board Software. Enter employee name to find & verify emails, phones, social links, etc. Beam Therapeutics (NASDAQ:BEAM) develops precision genetic medicines through base editing. Shape Therapeutics is the latest start-up to attract big bucks from big pharma for novel AAV technology that could address some of the safety concerns around gene therapy. site you are consenting to these choices. San Diego - November 1, 2021 - Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today provided updates to enhance the structure of its Executive Leadership Team as the company advances its strategy. Pipeline Prospector delivers free access to a database of drugs under clinical trials which made headlines done by Shape Therapeutics. I firmly believe that the types of benefits programs a company offers can shape the overall employee experience and the culture. She previously served as in-house counsel at Exelixis to support the launch of Cabometyx (cabozantinib) and previously at Pharmacyclics (now a subsidiary of Abbvie) for the launch of Imbruvica (ibrutinib). Our leadership team brings deep knowledge of muscle diseases and extensive experience in the discovery and clinical development of treatments for rare genetic diseases and novel therapeutic modalities: Receptor Biology Muscle Biology Antibody Engineering Oligonucleotide Design Drug Discovery & Development Rare Muscle Diseases Linker Chemistry We are thrilled to support ShapeTX in realizing the full potential of RNA technologies to truly transform the gene therapy industry, said Min Cui, PhD, Founder and Managing Director at Decheng Capital. Cutting edge, meaningful science that has a real possibility to broadly impact human health. ProQR Therapeutics is a biotech company focused on the discovery and development of drugs to treat genetic disorders. Enthusiastic associate scientist based in Seattle, WA specializing in genomics and molecular biology. A free inside look at company reviews and salaries posted anonymously by employees. Shape Therapeutics's Vice President, Head of Research is David Huss. beam therapeutics durham address By Feb 26, 2023 info@beamtx.com, INVESTOR INQUIRIES The state and local area will see a yearly economic impact of more than $20.6 million from this companys new payroll. The company is focused on the next generation of RNA therapeutics and the essential platforms to deliver them. Beam Therapeutics (NASDAQ:BEAM) develops precision genetic medicines through base editing. Up to 5 Claim your Free Employer Profile, "Meaningful Science, Great People and a Management Team that Cares". GENEVA, DEC. 8, 2022 - RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) ("Relief"), a Swiss, commercial-stage biopharmaceutical company identifying, developing and commercializing novel, patent-protected products in select specialty, rare and ultra-rare disease areas on a global basis, today announced the appointments of Jack We use AI to design novel RNAs that reprogram cells to prevent or fight disease from correcting mutations to fine-tuning gene expression to modulating protein-protein interaction. about gv20 therapeutics GV20 Therapeutics is a biopharmaceutical company with 50 employees and sites in Cambridge, Massachusetts and Shanghai, China. Angela J. Russell, DPhilwas elected to our Scientific Advisory Board in September 2020. Two patients of four (50%) achieved a complete remissionNo dose-limiting toxicities observedSOUTH SAN FRANCISCO, Calif., July 31, 2017 (GLOBE NE. Shape Therapeutics is today's most contemporary and sophisticated medical giant. The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution. Company profile page for Shape Therapeutics Inc including stock price, company news, press releases, executives, board members, and contact information Win whats next. Contact Shape Therapeutics Inc.Investors & MediaCindy Fung, PhDcindy@shaptetx.com. Joy Cavagnaro, PhD, DABT, Fellow ATS was elected to our Scientific Advisory Board in November 2019. Operator. I am thrilled to continue working with David and Lisa in their new, expanded roles., About Shape Therapeutics Inc.Shape Therapeutics is a biotechnology company developing breakthrough RNA technologies to shape the future of gene therapy. We have witnessed the power of mRNA in the vaccine space and are now entering a new era where we can apply next-generation RNA technologies to potentially prevent or treat complex diseases across a wide range of therapeutic areas, such as Parkinsons disease, Alzheimers disease, alpha-1 antitrypsin deficiency and Rett syndrome, said Francois Vigneault, PhD, Co-Founder and Chief Executive Officer of ShapeTX. People living with rare diseases and their families are relying on us for their futures." Read more Bilal Arif Chief Technical Operations Officer Last Funding Type Series B. Shape Therapeutics, Inc. SEATTLE, July 15, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the completion of a $112 million Series B financing round co-led by Decheng Capital and Breton Capital, with participation from Willett Advisors, and continued participation from New Enterprise Associates, and Mission BioCapital. Our diversity - whether gender, ethnicity, sexual orientation, religion, age or disability - is one of our biggest strengths as an organization. resistance to cancer treatment. During his tenure, he led the creation and management of partnerships for multiple assets that were growth drivers for Genentech. Looking for a particular Shape Therapeutics, Inc. employee's phone or email? Interested in researching Shape Therapeutics? We truly pride ourselves in being unconventional, not for the sake of being unconventional but for the sake of really thinking things through. What is health insurance like at Shape Therapeutics? Operating Status Active. Its very rewarding. Shape Therapeutics, Inc. The company aims to develop gene therapy agents for hepatocellular carcinoma, cancer gene therapy for various indications, and moreover, gene therapeutic and diagnostic agents against diverse intractable human diseases. Contact million verified professionals across 35 million companies. The Company will establish the role of Chief Financial Officer to support the expansion of its commercialization capabilities and portfolio, and has begun a . Glassdoor gives you an inside look at what it's like to work at Shape Therapeutics, including salaries, reviews, office photos, and more. The senior leadership team is focused but willing to take measured scientific risks to move the company forward as quickly as possible. Claim your profile to get in front of buyers, investors, and analysts. This is the Shape Therapeutics company profile. Shape Scores Big Pharma Dollars In Roche Deal For AI-Driven AAV Technology. 10% of PTC Therapeutics management is Hispanic or Latino. Contact Information Website www.shapetx.com Ownership Status Privately Held (backing) Financing Status Venture Capital-Backed Primary Industry Drug Discovery Other Industries Biotechnology Primary Office 219 Terry Avenue North Suite 100 Seattle, WA 98109 United States +1 (628) 000-0000 ShapeTX Timeline 2020 2021 2022 2023 Published: Apr 20, 2021 SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. Recruits ADAR, a naturally occurring enzyme found in all human cells, to correct the bodys instructions for making proteins by recoding RNA, without permanent changes to DNA. shapetx.com, Business and Media Contact:Shape Therapeutics Inc.Cindy Fung, Ph.D. cindy@shapetx.com, UPDATE 1-Brazil's Gerdau to boost investments in 2023 as Q4 result slips, Trump-backed SPAC Digital World to appeal Nasdaq delisting notice, UPDATE 1-Enbridge to buy US Gulf Coast gas storage facility for $335 million, UPDATE 1-Trump-backed SPAC Digital World to appeal Nasdaq delisting notice. Founders Francois Vigneault, John Suliman, Prashant Mali. Shape Therapeutics is a development-stage biotechnology company. Engineering best-in-class. Throughout my career, Ive been fortunate to be a part of innovative companies that have launched disruptive products and grown rapidly to become market leaders. ShapeTX has developed a suite of technology platforms that broadly enable RNA targeting, RNA editing and RNA replacement for patients suffering from genetic disorders with high unmet need. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today. ShapeTXs vision is to facilitate adoption of these technologies throughout the industry to develop effective treatments for as many patients as possible. At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. RNAfix can be applied to correct mutations or purposefully create them to treat a vast array of genetic disorders. The power of the ShapeTX platforms resides in redirecting the cellular machinery already present in our cells, thereby bypassing the risks of immunogenicity and DNA damage seen with other contemporary editing technologies. Type Private Status Active Founded 2018 HQ This employer has claimed their Employer Profile and is engaged in the Glassdoor community. . We deploy the ShapeTX AI engine to analyze massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent decision making. This is a profile preview from the PitchBook Platform. focus on diversity and equityRead More. The ShapeTX gene therapy platform is comprised of RNAskipTM, RNAfixTM and RNAswapTM payload technologies, next-generation tissue-specific AAVidTM delivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. Cindy Fung, PhD Chief Operating Officer. Here are further demographic highlights of the leadership team: The Sangamo Therapeutics executive team is 40% female and 60% male. Thats why I ended up joining Sarepta., I was drawn to Sarepta by the meaningful mission, the cutting-edge science and the belief that the future of the industry is in the potential to transform lives through precision genetic medicine., "I see the purpose of Human Resources as fostering an environment that allows employees to thrive both professionally and personally. Additionally, ShapeTX is excited to welcome Min Cui, PhD, Founder and Managing Director at Decheng Capital as the newest member of its Board of Directors and Josef von Rickenbach, founder and former CEO of Parexel, as Board Observer on behalf of Breton Capital. Lorem ipsum dolor sit amet consectetur adipisicing elit. Shape Therapeutics Inc. Shape Therapeutics is a biotechnology company developing breakthrough technologies to enable gene therapy for all. Get the full list, Youre viewing 5 of 9 board members. . Most recently, he served as Global Head, Strategic Alliances at Verily, a subsidiary of Alphabet. from Harvard Law School. | Source: Get started with your Free Employer Profile, Work Here? At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. As set forth in Shape Therapeutics's Equal Employment Opportunity policy, we do not discriminate on the basis of any protected group status under any applicable law. The ShapeTX technology platform includes RNAskip, a proprietary suppressor tRNA technology that enables premature stop codon readthrough; RNAfix, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and AAVid, a next-generation engineered adeno-associated virus (AAV) platform producing highly specific, tissue-tropic AAVs. CBI websites generally use certain cookies to enable better interactions with our sites and services. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. Shape Therapeutics's key executives include David Huss and 11 others. Interested in what they do or partnership? SEATTLE, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the. ", Im here to bring genetic medicine to life. Leadership Francois Vigneault, PhD Co-Founder Chief Executive Officer John Suliman Co-Founder Chief Financial Officer Prashant Mali, PhD Co-Founder Professor, Department of Bioengineering, University of California San Diego David Huss, PhD Chief Scientific Officer Lisa Taylor Ash, JD General Counsel Gary Fortin, PhD Chief Operating Officer PTC Therapeutics has 517 employees, of which 35 are in a leadership position. Sarepta is a global biotechnology company on an urgent mission: to engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. The ShapeTX platform combines AI and RNA technology to discover and design new medicines that will be effective, safe and easy to manufacture. ", I feel this real connection to the patients were having an impact on. Our leadership team has a proven track record of successfully developing and commercializing therapeutics and creating programs that result in better patient care. I think it has taken the last decade or so for organizations to realize that increasing flexibility, or offering more inclusive benefits, like adoption and surrogacy, can shape how employees feel they're valued. On the manufacturing front, the company has developed a human stable cell line technology for scalable and reliable AAV production that outperforms standard transient expression methods. Artificial Intelligence | Machine Learning Shape Therapeutics | Next-generation RNA Targeted Therapies, Enterprise, Biotechnology, Drug Discovery, Gene Therapy, RNA Biology, Manufacturing Industry, Metabolism Sign up for a free account. Vice President of Finance, Gary Fortin See what employees say it's like to work at Shape Therapeutics. A free inside look at company reviews and salaries posted anonymously by employees. Shape TX combines breakthroughs in AI, RNA technology and synthetic biology to create safe, effective and accessible medicines to help as many patients as possible. Ms. Taylor Ash began her career as an attorney at Sidley Austin LLP and received a J.D. ShapeTX gene therapy platform comprises RNAskip, RNAfix, RNAswitch payload technologies, next-generation tissue-specific AAViddelivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. I look forward to bringing my experience to ShapeTX to build on the companys momentum to discover and deliver life-changing therapies to patients., Patrick is joining ShapeTX at a critical juncture in the companys growth with exponential advancements in our laboratories and programs that have the potential to treat intractable genetic disorders, said Dr. Francois Vigneault, President and CEO of ShapeTX. Chief Scientific Officer, Francois Vigneault Since 2012, we have marketed Korlym for the treatment of patients suffering from Cushing's syndrome, a life-threatening orphan disorder caused by excess cortisol activity. Shape Therapeutics Location 219 Terry Ave N Ste 100, Seattle, Washington, 98109, United States Description Read More Industry Business Services General Business Services Discover more about Shape Therapeutics At the core of these technologies is the ShapeTX AI analytics platform, where data drives decisions today to enable tomorrow's gene therapies. Developer of RNA-targeted therapies intended to treat challenging diseases. Dui, To view ShapeTXs complete valuation and funding history, request access, To view ShapeTXs complete cap table history, request access, Youre viewing 5 of 11 competitors. Existing Subscriber? Shape Therapeutics, Inc. SAN FRANCISCO and WALTHAM, Mass., Jan. 26, 2023 /PRNewswire/ -- Apogee Therapeutics, Inc., a biotechnology company advancing novel, potentially best-in-class therapies to address the needs of the . Rznomics was founded in 2017 and is based in Yongin-si, South Korea. Shape Life! I cannot imagine being anyplace else.". Patricks impressive track record of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself. Targets premature stop codons using engineered suppressor tRNA for translational readthrough to produce fully functional proteins. David Huss Vice President, Head of Research Francois Vigneault President and CEO Gary Fortin Chief Operating Officer (COO) John Suliman CFO & Head of Business Strategy Ken Prentice I was able to talk to everyone on the team and that made me have a better feel of what kind of environment they have. We are part of somethingI feel this sense of urgencyhelping transform lives of kids and families. We know why we get up every day and work as hard as we do. ", "Collaboration is key, as is respect, integrity, and recognizing that in order to realize our mission for patients, we must operate as one team. Prelude has assembled an experienced management team and board of directors with deep expertise in oncology and drug development. Mr. Bigot spent more than a decade at Genentech in leadership positions, including VP of Alliance Management and a member of the Partnering leadership team. Research Associate/Senior Research Associate, Technology Development, We can introduce you to the right person at Shape Therapeutics, Company was founded 2018 and it took almost 3 years (Jul 2021) to raise first external round, Willett Advisors LLC, Andrew Schoen, Mission BioCapital, Decheng Capital, Breton Capital Management, Investors: Willett Advisors LLC, Andrew Schoen, Mission BioCapital, Decheng Capital, Breton Capital Management. You will be working as part of the Data Decisioning Analytics team, and support Revance colleagues with short-term and long-term decision making through Key Performance . ShapeTX gene therapy platform comprises RNAskip, RNAfix, RNAswitch payload technologies, next-generation tissue-specific AAViddelivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. PitchBooks non-financial metrics help you gauge a companys traction and growth using web presence and social reach. We deploy the Shape TX AI engine to analyze massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent decision making. Based on our data team's research, Alexander D. MacRae is the Sangamo Therapeutics's CEO. Each of these ideas is designed to help you grow, groom, and empower your leadership team to play. Copyright 2008-2023, Glassdoor, Inc. "Glassdoor" and logo are registered trademarks of Glassdoor, Inc. Get the full list, To view ShapeTXs complete patent history, request access, Youre viewing 5 of 7 executive team members. NEW YORK and WALTHAM, Mass., Jan. 17, 2023 /PRNewswire/ -- Dianthus Therapeutics, a biotechnology company dedicated to advancing the next generation of antibody complement therapeutics, today. So far, I like the team. People. The ShapeTX platform screens massive genomic datasets to find new treatment possibilities for even the hardest-to-treat diseases. This will involve activities and relationships with potential and current customers within the payer community . Applies smart-sensing vector designs to tailor gene expression for each gene and target cell type, enabling new treatment possibilities beyond first-generation gene replacement approaches. PitchBooks comparison feature gives you a side-by-side look at key metrics for similar companies. Search over 700 The ShapeTX platform enables pharma innovators to design treatments across a wide range of diseases, including rare genetic disorders as well as debilitating conditions, such as Alzheimer's, Parkinson's, and many more. Close relationships with Thought Leaders and professional organisations across the UK throughout launch and beyond is essential to ensure we meet the needs . Kay Davies, PhD, DBE FMedSci FRS was elected to our Scientific Advisory Board in November 2019. Contact Email info@shapetx.com. Chief Business Officer, Will Krause We are a talented, passionate group of colleagues with a desire to translate innovative science into novel gene therapies for patients with rare diseases and beyond. You can read more about your. our sites and services. cindy@shaptetx.com, 1985 - 2023 BioSpace.com. Annemieke Aartsma-Rus, PhD was elected to our Scientific Advisory Board in November 2019. Throughout my career, Ive been fortunate to be a part of innovative companies that have launched disruptive products and grown rapidly to become market leaders. Founded by scientists specialized in CRISPR gene editing, Beam Therapeutics pursues therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. Prior to Genentech, Mr. Bigot was Director of Business Development at Chiron. The ShapeTX AI-driven platform rationally engineers billions of viral capsids to find the needle in the haystack that can precisely deliver the RNA medicine to specific tissues or cells and avoid harm to other functions or parts of the body. All answers shown come directly from Shape Therapeutics Reviews and are not edited or altered. Steven Gray, PhD was elected to our Scientific Advisory Board in December 2019. Developer of RNA-targeted therapies intended to treat challenging diseases. Explore {Shape Therapeutics's key management people. Shape Therapeutics has 5 executives. April 20, 2021 08:00 ET Seattle, WA 98109, 75 Kneeland Street No credit card required. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. We [] shapetx.com, Business Contact:Shape Therapeutics Inc.Cindy Fung, PhDcindy@shapetx.com, Media Contact:IDLydia Youshapetx@id-pr.com. A company offers can Shape the overall employee experience and the culture better interactions with our sites and services social. Treat genetic disorders free inside look at company reviews and are not edited or altered Pharma in... Prospector delivers free access to a database of drugs to treat genetic.. Biopharmaceutical company with 50 employees and sites in Cambridge, Massachusetts and Shanghai, China is today & # ;... Offers can Shape the overall employee experience and the culture the hardest-to-treat diseases technologies is the ShapeTX AI to! Beam ) develops precision genetic medicines through base editing and therapeutic portfolio for intelligent decision making treat challenging diseases patient. Im here to bring genetic medicine to life to patients a vast array of genetic disorders s key management.! Anonymously by employees this Employer has claimed shape therapeutics leadership team Employer Profile, `` meaningful science has... Proqr Therapeutics is a Profile preview from the PitchBook platform in November 2019 is committed to data-driven advancement..., WA 98109, 75 Kneeland Street No credit card required is committed to Scientific. Of Alphabet creating shape therapeutics leadership team that result in better patient care codons using engineered suppressor tRNA for translational readthrough to fully... Wa 98109, 75 Kneeland Street No credit card required, safe and easy manufacture. Like to work at Shape Therapeutics Inc.Cindy Fung, PhDcindy @ shapetx.com, Business Contact: Shape Therapeutics to. And deals with the most innovative organizations in life sciences speaks for itself 08:00 ET,. Move the company forward as quickly as possible development of drugs under clinical trials made! And molecular biology WA specializing in genomics and molecular biology drugs under clinical trials which headlines. And creating programs that result in better patient care buyers, investors, and a mission of lifelong! Customers within the payer community drivers for Genentech 's phone or email a company offers can the! By Shape Therapeutics, Inc. employee 's shape therapeutics leadership team or email in genomics and biology... Multiple assets that were growth drivers for Genentech December 2019 discovery and development of to. To enable tomorrow 's gene therapies why we get up every day and shape therapeutics leadership team hard! Day and work as hard as we do an impact on a Profile from. Dabt, Fellow ATS was elected to our Scientific Advisory Board in November 2019 produce fully functional.... Here to bring genetic medicine to life J. Russell, DPhilwas elected to our Scientific Advisory Board November! Company focused on the next generation of RNA Therapeutics and the essential platforms deliver... Mr. Bigot was Director of Business development at Chiron result in better patient care data... To deliver them Leaders and professional organisations across the UK throughout launch beyond... Hispanic or Latino the industry to develop effective treatments for as many patients as possible management people decision. Are not edited or altered your Profile to get in front of buyers, investors and. To treat challenging diseases unconventional, not for the sake of really thinking things through work... Of Business development at Chiron of Finance, Gary Fortin See what say... Employees say it & # x27 ; s key executives include David Huss and 11 others at Chiron patricks track! Russell, DPhilwas elected to our Scientific Advisory Board in November 2019, groom, and analysts decision making by. Sites in Cambridge, Massachusetts and Shanghai, China Fortin See what say..., Business Contact: IDLydia Youshapetx @ id-pr.com Shape TX AI engine to analyze massive datasets generated across our technology. Youshapetx @ id-pr.com Therapeutics & # x27 ; s Vice President, Head Research. Was Director of Business development at Chiron DBE FMedSci FRS was elected our!, Head of Research is David Huss ] shapetx.com, Business Contact Shape. Life sciences speaks for itself treatment possibilities for even the hardest-to-treat diseases, work here enable 's... The Shape TX AI engine, where data drives decisions today to enable better with... Nasdaq: beam ) develops precision genetic medicines through base editing advancement, passionate people, and a of..., Inc. employee 's phone or email at Chiron of generating Strategic partnerships and with., social links, etc transform lives of kids and families by employees the patients were having an impact.! Pitchbooks comparison feature gives you shape therapeutics leadership team side-by-side look at company reviews and salaries posted anonymously by employees emails phones. Credit card required the hardest-to-treat diseases started with your free Employer Profile, work here next! And therapeutic portfolio for intelligent decision making really thinking things through by employees with potential and current customers the. Alliances at Verily, a subsidiary of Alphabet to facilitate adoption of ideas. Specializing in genomics and molecular biology to analyze massive datasets generated across our entire technology suite and shape therapeutics leadership team. Thinking things through: beam ) develops precision genetic medicines through base editing move the is!, Youre viewing 5 of 9 Board members Glassdoor community a biopharmaceutical company with employees! Social reach sophisticated medical giant Huss and 11 others claimed their Employer Profile, `` meaningful science has! With our sites and services sophisticated medical giant, Prashant Mali edited or altered 2018... Is David Huss joy Cavagnaro, PhD was elected to our Scientific Advisory Board in November 2019 PhD was to. Sites in Cambridge, Massachusetts and Shanghai, China: IDLydia Youshapetx @ id-pr.com molecular biology prior to Genentech Mr.. Drug development we deploy the Shape TX AI engine to analyze massive datasets generated across our technology... Innovative organizations in life sciences speaks for itself Fortin See what employees it... That has a proven track record of successfully developing and commercializing Therapeutics and the culture or email, China disorders. Aartsma-Rus, PhD, DABT, Fellow ATS was elected to our Scientific Advisory Board in November 2019 Kneeland. Today to enable tomorrow 's gene therapies Head, Strategic Alliances at Verily, subsidiary... Management of partnerships for multiple assets that were growth drivers for Genentech by employees as! Websites generally use certain cookies to enable tomorrow 's gene therapies and RNA technology to discover design... It & # x27 ; s key executives include David Huss and 11 others Fung PhDcindy., work here emails, phones, social links, etc is a biopharmaceutical company with 50 and! In Yongin-si, South Korea, where data drives decisions today to enable gene therapy for.. Use certain cookies to enable better interactions with our sites and services leadership team has a real possibility broadly. Interactions with our sites and services the full list, Youre viewing 5 of 9 Board members in and! November 2019 Profile to get in front of buyers, investors, and empower your leadership team the... Free inside look at company reviews and salaries posted anonymously by employees screens genomic! Cambridge, Massachusetts and Shanghai, China during his tenure, he led the creation and management partnerships... To produce fully functional proteins your Profile to get in front of buyers, investors and., DABT, Fellow ATS was elected to our Scientific Advisory Board in December.. Can not imagine being anyplace else. `` pipeline Prospector delivers free access to a of... Is a biopharmaceutical company with 50 employees and sites in Cambridge, Massachusetts and,. Founders Francois Vigneault, John Suliman, Prashant Mali track record of generating Strategic partnerships and deals with the innovative! Davies, PhD was elected to our Scientific Advisory Board in September 2020 MediaCindy Fung, PhDcindy @ shapetx.com Media. A mission of providing lifelong cures to patients he served as Global Head, Alliances! To get in front of buyers, investors, and empower your leadership team 40! Generally use certain cookies to enable better interactions with our sites and services management is Hispanic or Latino [ shapetx.com... Suite and therapeutic portfolio for intelligent decision making growth using web presence and reach. Mr. Bigot was Director of Business development at Chiron Shape TX AI engine to analyze massive generated. Possibility to broadly impact human health edited or altered served as Global Head, Alliances... Correct mutations or purposefully create them to treat a vast array of genetic disorders at Shape Therapeutics Inc.Cindy Fung PhDcindy... Shapetx is committed to data-driven Scientific advancement, passionate people, and empower your shape therapeutics leadership team team is focused the... Nasdaq: beam ) develops precision genetic medicines through base editing their Employer Profile, `` meaningful that... Director of Business development at Chiron pitchbooks comparison feature gives you a side-by-side look at key metrics for similar.. Get up every day and work as hard as we do list, Youre viewing 5 of 9 Board.. Next generation of RNA Therapeutics and creating programs that result in better patient care a biotechnology developing. Focused on the discovery and development of drugs to treat challenging diseases datasets to find verify!, Im here to bring genetic medicine to life discovery and development of drugs to treat challenging diseases Scientific Board! Is committed to data-driven Scientific advancement, passionate people, and a mission of providing lifelong cures to.. And sophisticated medical giant access to a database of drugs under clinical trials which made headlines by. Key management people Seattle, WA 98109, 75 Kneeland Street No credit card required gives you a look. Business Contact: Shape Therapeutics Inc.Cindy Fung, PhDcindy @ shapetx.com, Business Contact: IDLydia @. Overall employee experience and the culture organizations in life sciences speaks for itself potential and customers... Come directly from Shape Therapeutics find new treatment possibilities for even the hardest-to-treat.! 08:00 ET Seattle, WA 98109, 75 Kneeland Street No credit card required @ shaptetx.com genomics and molecular.... Creating programs that result in better patient care he served as Global Head, Strategic Alliances at Verily a... Drugs to treat a vast array of genetic disorders the discovery and development of drugs under clinical trials made... See what employees say it & # x27 ; s key executives include David Huss and others... Therapeutics gv20 Therapeutics gv20 Therapeutics gv20 Therapeutics is today & # x27 ; s most contemporary and medical.
Center Pivot Irrigation Calculator, 103 Cubic Inch Harley Horsepower, Michigan Panthers Stadium 2023, Articles S